1. Home
  2. IIPR vs BHVN Comparison

IIPR vs BHVN Comparison

Compare IIPR & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Industrial Properties Inc.

IIPR

Innovative Industrial Properties Inc.

HOLD

Current Price

$57.10

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.72

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIPR
BHVN
Founded
2016
2013
Country
United States
United States
Employees
23
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
IIPR
BHVN
Price
$57.10
$9.72
Analyst Decision
Hold
Buy
Analyst Count
3
14
Target Price
$45.00
$29.08
AVG Volume (30 Days)
337.2K
1.6M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
14.28%
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.69
N/A
Revenue Next Year
$3.80
N/A
P/E Ratio
$10.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.58
$7.48
52 Week High
$61.40
$18.57

Technical Indicators

Market Signals
Indicator
IIPR
BHVN
Relative Strength Index (RSI) 57.49 48.51
Support Level $52.47 $9.26
Resistance Level $57.58 $10.22
Average True Range (ATR) 2.62 0.71
MACD 0.37 -0.02
Stochastic Oscillator 52.14 37.76

Price Performance

Historical Comparison
IIPR
BHVN

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: